The role of substrate topography on the cellular uptake of nanoparticles
Improving targeting efficacy has been a central focus of the studies on nanoparticle (NP)-based drug delivery nanocarriers over the past decades. As cells actively sense and respond to the local physical environments, not only the NP design (e.g., size, shape, ligand density, etc.) but also the cell...
Saved in:
Published in | Journal of biomedical materials research. Part B, Applied biomaterials Vol. 104; no. 3; pp. 488 - 495 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.04.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Improving targeting efficacy has been a central focus of the studies on nanoparticle (NP)-based drug delivery nanocarriers over the past decades. As cells actively sense and respond to the local physical environments, not only the NP design (e.g., size, shape, ligand density, etc.) but also the cell mechanics (e.g., stiffness, spreading, expressed receptors, etc.) affect the cellular uptake efficiency. While much work has been done to elucidate the roles of NP design for cells seeded on a flat tissue culture surface, how the local physical environments of cells mediate uptake of NPs remains unexplored, despite the widely known effect of local physical environments on cellular responses in vitro and disease states in vivo. Here, we report the active responses of human osteosarcoma cells to fibrous substrate topographies and the subsequent changes in the cellular uptake of NPs. Our experiments demonstrate that surface topography modulates cellular uptake efficacy by mediating cell spreading and membrane mechanics. The findings provide a concrete example of the regulative role of the physical environments of cells on cellular uptake of NPs, therefore advancing the rational design of NPs for enhanced drug delivery in targeted cancer therapy. |
---|---|
Bibliography: | National Science Foundation - No. CMMI 13-34847 ArticleID:JBMB33397 ark:/67375/WNG-BQGLVQ9R-H National Institutes of Health - No. R21EB019230 istex:C358B961F5ADEC263B07B47B0ED7CAFA546DF95C National Science Foundation - No. CMMI-0754463; CBET-1067523 National Institutes of Health - No. R21HL122902 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Both authors contributed equally to this work. |
ISSN: | 1552-4973 1552-4981 |
DOI: | 10.1002/jbm.b.33397 |